You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Article metrics

Article menu

Download PDFPDF

Research Article
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019550
Jan 2020662
Feb 2020771
Mar 202019190
Apr 2020993
May 202022225
Jun 202016164
Jul 202015152
Aug 202016162
Sep 202025250
Oct 202030303
Nov 202018182
Dec 202018183
Jan 202126265
Feb 202117171
Mar 202125255
Apr 202119192
May 202116162
Jun 202138388
Jul 202113131
Aug 202121212
Sep 2021232310
Oct 202118183
Nov 202114147
Dec 202122222
Jan 202228295
Feb 202219216
Mar 202215154
Apr 2022323710
May 202231313
Jun 202222220
Jul 202217182
Aug 202226264
Sep 2022191910
Oct 202232322
Nov 2022101511
Dec 202216167
Jan 202317174
Feb 202319191
Mar 202312129
Apr 20238917
May 202312122
Jun 2023991
Jul 202312127
Aug 202318183
Sep 202336363
Oct 202366664
Nov 20231161161
Dec 202329294
Jan 202437385
Feb 2024414111
Mar 2024232310
Total11801196221